Northern blotting, binding of PRIC285 to PPARα, and colocalization. (A) Northern analysis of human multiple tissue blot (CLONTECH). Lanes 1–12 represent, respectively, brain, heart, skeletal muscle, colon, thymus, spleen, kidney, liver, small intestine, placenta, lung, and leukocytes. Arrow indicates PRIC285 mRNA. (B) Northern analysis of human cancer cell line blot (CLONTECH) probed with a partial PRIC285 cDNA probe. Lanes 1–8 represent, respectively, HL-60 cells line, HeLa cell S3, chronic myelogenous leukemia (K-562), lymphoblastic leukemia MOLT-4, Burkitt's lymphoma Raji, colorectal adenocarcinoma SW480, lung carcinoma A-549, and melanoma G-361. Arrow indicates PRIC285 mRNA. (C) [35S]Methionine-labeled full-length PRIC285 generated by in vitro translation was incubated with GSH-Sepharose beads bound with purified E. coli-expressed GST-PPARα or GST. PRIC285 bound to PPARα in the absence of ligand, and the addition of ligand increased the binding ≈2-fold. PRIC285 also interacts with PPARγ, RXRα, ERα (estrogen receptor α), and TRβ1 (thyroid hormone receptor β1). (D and E) Colocalization of PRIC285 and PPARα in the nucleus as visualized by conventional fluorescence microscopy (D) and by DELTAVISION deconvolution microscopy (E). PRIC285 was expressed transiently in HEK293 cells by using three FLAG epitopes linked to the C terminus, and it was visualized by using anti-FLAG antibodies (green). PPARα was also transiently expressed in these cells and localized by using anti-PPARα antibodies (red). Merging of the PRIC285 and PPARα localization images of the same cell reveals overlapping localization (yellow) of these two proteins. 4×,6-Diamidino-2-phenylindole (DAPI) staining shows nuclei in D (Lower Right).